Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · Real-Time Price · USD
187.77
+2.35 (1.27%)
Dec 20, 2024, 4:00 PM EST - Market closed
Inspire Medical Systems Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 33.05 | -21.15 | -44.88 | -42.04 | -57.2 | -33.24 | Upgrade
|
| Depreciation & Amortization | 4.89 | 2.85 | 1.86 | 1.22 | 0.84 | 0.5 | Upgrade
|
| Other Amortization | - | - | - | - | - | 0.27 | Upgrade
|
| Loss (Gain) From Sale of Investments | -9.72 | -2.47 | -0 | 0.01 | - | -0.98 | Upgrade
|
| Stock-Based Compensation | 110.07 | 82.82 | 52.3 | 26.48 | 13.11 | 6.43 | Upgrade
|
| Other Operating Activities | 3.24 | 3.39 | 0.49 | 1.07 | 1.09 | 0.76 | Upgrade
|
| Change in Accounts Receivable | -17.28 | -30.22 | -27.02 | -9.24 | -11.84 | -6.48 | Upgrade
|
| Change in Inventory | -41.32 | -22 | 5.35 | -8.75 | -2.65 | -3.17 | Upgrade
|
| Change in Accounts Payable | -5.14 | 9.3 | 14.36 | 4.78 | 2.05 | 1.03 | Upgrade
|
| Change in Other Net Operating Assets | 3.02 | 2.14 | 9.13 | 6.36 | 1.56 | 2.04 | Upgrade
|
| Operating Cash Flow | 78.33 | 24.65 | 11.57 | -20.12 | -53.05 | -32.85 | Upgrade
|
| Operating Cash Flow Growth | 193.87% | 113.10% | - | - | - | - | Upgrade
|
| Capital Expenditures | -40.13 | -23.63 | -9.1 | -4.67 | -2.46 | -2.74 | Upgrade
|
| Investment in Securities | -228.48 | -271.19 | -10.5 | 33.81 | 89.08 | -40.82 | Upgrade
|
| Investing Cash Flow | -268.61 | -294.82 | -19.6 | 29.14 | 86.63 | -43.56 | Upgrade
|
| Long-Term Debt Repaid | - | - | -24.5 | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | - | - | -24.5 | - | - | - | Upgrade
|
| Issuance of Common Stock | 30.6 | 31.11 | 259.62 | 14.95 | 134.07 | 2.5 | Upgrade
|
| Repurchase of Common Stock | -22.97 | -17.16 | -0.04 | - | - | - | Upgrade
|
| Other Financing Activities | - | - | - | - | - | -0.53 | Upgrade
|
| Financing Cash Flow | 7.63 | 13.95 | 235.08 | 14.95 | 134.07 | 1.96 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.26 | 0.16 | 0.08 | -0.02 | 0.01 | 0.01 | Upgrade
|
| Net Cash Flow | -182.39 | -256.06 | 227.13 | 23.95 | 167.66 | -74.43 | Upgrade
|
| Free Cash Flow | 38.2 | 1.02 | 2.47 | -24.79 | -55.5 | -35.59 | Upgrade
|
| Free Cash Flow Growth | 371.12% | -58.59% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | 5.06% | 0.16% | 0.61% | -10.62% | -48.10% | -43.37% | Upgrade
|
| Free Cash Flow Per Share | 1.26 | 0.03 | 0.09 | -0.91 | -2.13 | -1.49 | Upgrade
|
| Cash Interest Paid | - | - | 2.32 | 1.89 | 1.89 | 2.03 | Upgrade
|
| Levered Free Cash Flow | 21.27 | 0.38 | 17.76 | -10.69 | -34.6 | -23.91 | Upgrade
|
| Unlevered Free Cash Flow | 21.27 | 0.38 | 18.81 | -9.36 | -33.27 | -22.85 | Upgrade
|
| Change in Net Working Capital | 62 | 36.49 | -3.49 | 7.48 | 9.64 | 5.23 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.